Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2026-05-18 @ 2:51 PM
Study NCT ID:
NCT05020392
Status:
UNKNOWN
Last Update Posted:
2023-07-25
First Post:
2021-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
auto-CART-CD19 cells and BTKi
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |